EPIRUS Biopharmaceuticals, Inc. Restructuring Charges
EPIRUS Biopharmaceuticals, Inc. reported Restructuring Charges of -$18.00 thousand for the 3-month period ending 2012-12-31, per its 10-K filed 2014-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2014-03-14
- EPIRUS Biopharmaceuticals, Inc. restructuring charges for the quarter ending 2012-12-31 was -$18.00K.
- EPIRUS Biopharmaceuticals, Inc. restructuring charges for the quarter ending 2012-09-30 was -$17.00K.
- EPIRUS Biopharmaceuticals, Inc. restructuring charges for the quarter ending 2012-06-30 was $28.00K.
- EPIRUS Biopharmaceuticals, Inc. restructuring charges for the quarter ending 2012-03-31 was $1.10M.
- EPIRUS Biopharmaceuticals, Inc. restructuring charges for fiscal 2012 was $1.09M.
- EPIRUS Biopharmaceuticals, Inc. restructuring charges for fiscal 2009 was $2.74M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$18.00K 10-K · filed 2014-03-14 | -$35.00K derived: sum of 2 quarters · filed 2014-03-14 | -$7.00K derived: sum of 3 quarters · filed 2014-03-14 | $1.09M 10-K · filed 2014-03-14 |
| 2012-09-30 | -$17.00K 10-K · filed 2014-03-14 | $11.00K derived: sum of 2 quarters · filed 2014-03-14 | $1.11M 10-Q · filed 2013-11-04 | |
| 2012-06-30 | $28.00K 10-K · filed 2014-03-14 | $1.13M 10-Q · filed 2013-08-05 | ||
| 2012-03-31 | $1.10M 10-K · filed 2014-03-14 | |||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-04 | |||
| 2009-12-31 | $2.74M 10-K · filed 2012-03-09 |